These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3284555)

  • 21. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
    Schüpbach J; Tanner M
    Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.
    Sarin PS; Sun DK; Thornton AH; Naylor PH; Goldstein AL
    Science; 1986 May; 232(4754):1135-7. PubMed ID: 3010464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization epitopes on HIV pseudotyped with HTLV-I: conservation of carbohydrate epitopes.
    Sørensen AM; Nielsen C; Arendrup M; Clausen H; Nielsen JO; Osinaga E; Roseto A; Hansen JE
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):116-23. PubMed ID: 7507991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.
    Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC
    J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1985 Jun; 76(6):432-5. PubMed ID: 2991058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.
    Arendrup M; Sönnerborg A; Svennerholm B; Akerblom L; Nielsen C; Clausen H; Olofsson S; Nielsen JO; Hansen JE
    J Gen Virol; 1993 May; 74 ( Pt 5)():855-63. PubMed ID: 7684062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.
    Albert J; Bredberg U; Chiodi F; Böttiger B; Fenyö EM; Norrby E; Biberfeld G
    AIDS Res Hum Retroviruses; 1987; 3(1):3-10. PubMed ID: 3040053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluations of the effect of UV irradiation on the infectivity of HTLV-III (AIDS virus) with HTLV-I-carrying cell line, MT-4.
    Nakashima H; Koyanagi Y; Harada S; Yamamoto N
    J Invest Dermatol; 1986 Aug; 87(2):239-43. PubMed ID: 3016104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
    Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL
    Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
    Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
    J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
    Ranki A; Weiss SH; Valle SL; Antonen J; Krohn KJ
    Clin Exp Immunol; 1987 Aug; 69(2):231-9. PubMed ID: 3652531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-2 antisera cross-neutralize HIV-1.
    Weiss RA; Clapham PR; Weber JN; Whitby D; Tedder RS; O'Connor T; Chamaret S; Montagnier L
    AIDS; 1988 Apr; 2(2):95-100. PubMed ID: 3132953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV).
    Harada S; Yamamoto N; Hinuma Y
    J Virol Methods; 1987 Dec; 18(4):291-303. PubMed ID: 2450887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of HTLV-III antibodies in immune serum globulin preparations.
    Lai-Goldman M; McBride JH; Howanitz PJ; Rodgerson DO; Miles JA; Peter JB
    Am J Clin Pathol; 1987 May; 87(5):635-9. PubMed ID: 3554975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of rhinovirus intertypes related to either rhinoviruses 12 and 78 or 36 and 58.
    Halfpap LM; Cooney MK
    Infect Immun; 1983 Apr; 40(1):213-8. PubMed ID: 6299958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.
    Balzarini J; Pauwels R; Herdewijn P; De Clercq E; Cooney DA; Kang GJ; Dalal M; Johns DG; Broder S
    Biochem Biophys Res Commun; 1986 Oct; 140(2):735-42. PubMed ID: 3022729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.
    Robinson WE; Montefiori DC; Mitchell WM
    Biochem Biophys Res Commun; 1987 Dec; 149(2):693-9. PubMed ID: 3426595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.